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Central Venous Access Devices in children; 
at a glance 
Introduction and indications 
Central Venous Access Devices (CVADs) are commonly used in the medical care of children for both 
short- and long-term care. Healthcare professionals caring for children who have CVADs in place, are 
required to have a clear understanding of the benefits and risks associated with their use. This ‘at a 
glance’ article introduces the different CVADs commonly used in paediatrics and offers step by step 
guidance on the use and care of these devices. 
NICE (2014) note that devices which provide vascular access to patients are one of the greatest 
causes of healthcare-associated infections. Furthermore, they note that bloodstream infections. 
associated with CVADs are a major cause of morbidity in patients (NICE, 2014). This reinforces the 
need for healthcare professionals caring for patients with CVADs to have an excellent understanding 
of infection prevention and control when using these devices. 
Central Venous Access Devices 
A CVAD is a catheter, which is inserted into a large vein in a child’s body and leads to the heart. The 
catheter is inserted through the skin and the tip will usually sit in either the superior vena cava or 
caval atrial junction (Royal Marsden NHS Foundation Trust, 2016) (Please redraw this diagram of 
heart or similar). 
   
A CVC was first inserted in 1929, and since this time, the use of CVADs in modern medicine has vastly 
grown and developed (Smith and Nolan, 2013). There are many different reasons why a child may 
need to have a CVAD inserted to provide access to large veins in the body, including; blood sampling, 
medication administration and central venous pressure monitoring in seriously unwell children. 
Table 1 displays the common CVADS used in Children, as well as their various uses, advantages and 
disadvantages. 
Different Types of CVAD’s used in Children 
Tunnelled central venous catheter (Please redraw this picture of tunnelled central line or similar) 
 
A tunnelled Central Venous Catheter (CVC) is sometimes known as a Hickman® or Broviac® line 
(named after the developers of each line). These catheters are tunnelled from an exit site, usually on 
the chest wall, up to the neck, where a small incision is made and the catheter is inserted into the 
superior vena cava (Children’s Cancer and Leukamia Group, (CCLG), 2020). There is a cuff on the line 
which is used to fix the line in place under the patient’s skin and the lines are initially surgically 
stitched into place. The tip of the tunnelled CVC usually sits at the entrance of the right atrium, 
providing access for blood sampling and drug administration. 
Tunnelled CVCs will usually only have one tube within the catheter but is also possible to get double, 
triple, quad or quin lumen CVCs where the catheter will be divided into up to five lumens in order to 
use each lumen in a different way. This is particularly useful for patients who require many different 
treatments simultaneously which may not be compatible, for example a patient who requires Total 
Parenteral Nutrition (TPN) at the same time as numerous IV medications. 
None tunnelled central venous catheters 
A none tunnelled CVC is very similar to a tunnelled catheter but the entrance point of the catheter to 
the body is directly through the skin and into the vein. None tunnelled CVC’s are usually used for 
shorter term, emergency access and are inserted in central veins in the chest neck or groin. 
Implantable Ports  
 
(Please redraw this picture of an implanted Portacath or similar) 
An implantable port or ‘Portacath’ is an implanted device which is fixed under the skin, usually on 
either the chest wall or forearm and is accessed using a hollow needle. The device has a reservoir 
that is connected to a catheter that leads into a central vein in the body. The reservoir of the device 
is covered with a self-sealing silicone and in order to access the reservoir of the device, and 
therefore the blood supply, a needle must be inserted through this silicone and fixed in place. When 
the port is not in use, the needle is removed and the child is able to maintain a more normal life 
(including going swimming) with a greatly reduced chance of infection, compared to with other 
CVADs. 
As with tunnelled CVADs, these implanted ports are tunnelled from the port site, usually on the 
chest, up to the neck, where a small incision is made and the catheter is inserted into the superior 
vena cava (Children’s Cancer and Leukamia Group, (CCLG), 2020). Though it is possible to get double 
ported implantable ports, which have separate lines to enable separate usages and require accessing 
with two needles, a single port is the most commonly used.  
Peripherally Inserted Central Catheters (PICC)  
 
(Please redraw picture of PICC line or similar) 
Peripherally Inserted Central Catheters (PICC) are usually tunnelled from the cephalic, median 
cubital or basilic vein in the anticubital region of the arm into the superior vena cava (CCLG, 2020). 
PICCs can also have numerous lumens if required in order to facilitate multiple usages. Though the 
length of time a PICC can be inserted varies, their recommended usage is usually around six weeks. 
This therefore makes this CVAD useful for children who may require central venous access for an 
intermittent period such as 6 weeks of IV antibiotic treatment or temporary nutritional support from 
TPN.  
Table 1. Commonly used CVADs in Children 
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How to access and care for a CVAD 
All healthcare professionals, parents and carers who access and care for CVADs in children need to 
have undertaken relevant training and had practical supervision before they are deemed competent 
in the use of CVADs (GAIN, 2014). When accessing or caring for a CVAD, it is essential that Aseptic 
Non-Touch Technique (ANTT) is used in order to prevent infection (GAIN, 2014). Though the below is 
a useful guide, it is important that the healthcare professional follows local guidance for use of ANTT 
as this may vary across healthcare settings. 
Accessing an Implantable Port with a non-coring safety needle (GAIN, 2014). 
Step 1 
Local anaesthetic cream may be applied under aseptic conditions before accessing the device. This 
should be removed after the appropriate amount of time. 
Step 2 
Prepare equipment, choosing an appropriate length of needle which is selected depending on the 
amount of subcutaneous tissue over the port and the depth of the reservoir. 
Step 3 
Hand cleaning should be carried out using the correct hand hygiene technique using either alcohol 
hand rub for 20-30 seconds or soap and water for 40-60 seconds. 
Step 4 
Under aseptic conditions, disinfect the skin around the Implantable Port site with 2% chlorhexidine 
and 70% isopropyl alcohol (NICE, 2014; Loveday et al, 2014). Allow the solution to dry. 
Step 5 
Insert the needle through the skin and septum, into the reservoir of the Implantable Port, ensuring 
the needle hits the back plate and sits flush against the skins surface. 
Step 6 
Ensure the correct placement of the needle through the aspiration of blood. 
Step 7 
Flush and lock the CVAD as described in table 1. 
Step 8 
Secure the needle with a sterile, transparent, semi-permeable dressing. 
 
Accessing a CVAD (for the purpose of flushing the device) (GAIN, 2014). 
Step 1 
Hand cleaning should be carried out using the correct hand hygiene technique using either alcohol 
hand rub for 20-30 seconds or soap and water for 40-60 seconds. 
Step 2 
The hub of the CVAD should be disinfected with an alcoholic chlorhexidine gluconate solution, 
usually a 2% chlorhexidine gluconate in 70% isopropyl alcohol wipe, and left to dry for 15 seconds 
(NICE, 2014; Loveday et al, 2014). 
Step 3 
Syringes to be connected to CVAD should preferably be 10ml in size to avoid high pressure causing 
the catheter to rupture and use a male/female luer lock. Once the syringe is connected, undo the 
clamp on the CVAD. 
Step 4 
Flush with the amount of sodium chloride 0.9% appropriate to the catheter in use as described in 
table 1, using a brisk push-pause or pulsating method to prevent reflux of blood. If appropriate, lock 
the line as described in table 1. 
Important note: Before flushing an implantable port device, it is necessary to obtain a flashback of 
blood to ascertain that the needle has not become dislodged. 
Step 5 
Once the line is flushed/locked, clamp the line in the specially reinforced area of the CVAD to 
prevent air entry and bleeding in the case of the luer lock cap becoming damaged or detached from 
the CVAD. 
Important note: If the CVAD has more than one lumen, each lumen should be accessed and flushed 
individually. 
Table 1 (GAIN, 2014, p20). There may be local variances to this guidance. 
CVAD Type Intermittent Drug 
Administration within 
a 24 hour period 
Intermittent Blood 
Sampling 
Not in use 
Short term CVC in 
acute care setting. 
Flush with at least 1ml 
Sodium Chloride 0.9% 
injection before drug 
and up to 3ml Sodium 
Flush with 1ml Sodium 
Chloride 0.9% 
injection after blood 
sample, followed by 
Heparin Sodium 
Flush daily with 1ml 
Sodium Chloride 0.9% 
injection followed by 
2ml Heparin Sodium 
Chloride 0.9% 
injection after drug. 
Flushing Solution 10 
units/ml. 




Flush with at least 1ml 
Sodium Chloride 0.9% 
injection before drug 
and up to 3ml Sodium 
Chloride 0.9% 
injection after drug. 
Flush with 1ml Sodium 
Chloride 0.9% 
injection after blood 
sample, followed by 
Heparin Sodium 
Flushing Solution 10 
units/ml.  
Flush on alternate 
days with 1ml Sodium 
Chloride 0.9% 
injection followed by 
2ml Heparin Sodium 




Flush with Sodium 
Chloride 0.9% 
injection before drug 
and after drug 
administration. Draw 
up to 3.5ml Sodium 
Chloride 0.9% and 
inject 3ml. 
Flush with 2ml Sodium 
Chloride 0.9% 
injection after blood 
sample, then flush 
with Heparin Sodium 
Flushing Solution 10 
units/ml. Draw up 
2.5ml Heparin Sodium 
Flushing Solution 10 
units/ml and inject 
2ml. 
Flush once or twice 
weekly. Draw up 
2.5ml Heparin Sodium 
Flushing Solution 10 
units/ml and inject 
2ml. 
Implanted Port Ensure flashback of 
blood.  
Flush with up to 3ml 
Sodium Chloride 0.9% 
injection before drug 
and after each drug 
and lock with 2ml 
Heparin Sodium 
Flushing Solution 10 
units/ml. 
For administration of 
drugs or blood 
sampling daily or less 
frequently: Prior to 
flushing, ensure 4ml 
of blood is discarded 
to remove heparinised 
saline. Flush with 10ml 
Sodium Chloride 0.9% 
injection and clamp 
the line. Lock with 4ml 
Heparin Sodium 
Flushing Solution 100 
units/ml. 
Flush monthly. Prior 
to flushing, ensure 
4ml of blood is 
discarded to remove 
heparinised saline. 
Flush with 10ml 
Sodium Chloride 0.9% 
injection and clamp 
the line. Lock with 4ml 
Heparin Sodium 
Flushing Solution 100 
units/ml. 
 
Care of dressings on a CVAD device (GAIN, 2014) 
Healthcare professionals should always follow local guidelines as these may vary in dressing choice 
and use of ANTT. CVAD devices should be dressed by placing a sterile, transparent, semi-permeable 
polyurethane dressing over the insertion site. Dressings that are clean, dry and intact can be 
changed every 7 days but any dressings which become compromised may need to be changed more 
frequently. 
Step 1 
Apply gloves and remove the old dressing from the CVAD. 
Step 2 
Hand cleaning should be carried out using the correct hand hygiene technique using either alcohol 
hand rub for 20-30 seconds or soap and water for 40-60 seconds. 
Step 3 
Disinfect the insertion site using 2% chlorhexidine and 70% isopropyl alcohol and allow to dry (NICE, 
2014; Loveday et al, 2014). 
Step 4 
Apply a new sterile, transparent, semi-permeable polyurethane dressing over the insertion site 
ensuring that the dressing fully covers the insertion site and is well adhered to the patient’s skin. 
Daily Care of a CVAD device (GAIN, 2014) 
 
All children with a CVAD are at increased risk of infection and as such require close monitoring. Daily 
care of a child with a CVAD should include a daily visual inspection of the insertion site of the CVAD 
to look for signs of redness, swelling or pus formation. Children with tunnelled CVADs may also be 
monitored to look for signs of redness tracking along the tunnelling of the CVAD. 
When a CVAD is in use, children should also be monitored for signs of infiltration and extravasation 
at the exit site and along the tunnelling of the CVAD. Infiltration is the administration of non-vesicant 
fluids outside of the vein and extravasation is the administration of vesicant fluids which may cause 
vein damage and rupture (Tofani et al, 2012). Signs of infiltration or extravasation include swelling, 
pain and redness, and a Visual Infusion Phlebitis (VIP) score is usually recommended throughout 
boluses and short infusions, and hourly when the line is in continuous use. 
Clinical considerations 
Routine Use of Heparin locks 
Though local guidance may vary, the Regional Medicines Optimisation Committee (RMOC, 2019) 
recommends that there is no need to routinely use heparinised saline lock for the purpose of 
maintaining the patency of a central venous catheter (CVC). There is an associated number of 
disadvantages to the routine use of heparinised saline which includes and increased demand on 
aseptic services and the exposure of patients to an active medicine that could cause side effects 
(RMOC, 2019). 
Aspirating CVADs in Children 
Though local policies may vary, and past evidence has argued that there is benefit to aspirating all 
CVADs before use to reduce the risk of pulmonary emboli (Coulthard and Skinner, 2007), the GAIN 
(2014) guidance does not advocate the routine aspiration of standard paediatric CVADs before each 
use. It is necessary, however, to aspirate and discard a small volume of blood prior to taking a blood 
sample to ensure the accuracy of the blood sample. GAIN guidelines (2014) do not specify what 
volume of blood should be discarded, so healthcare professionals should refer to their local policies, 
however, research has shown that a volume of discard of 3mls was demonstrated to be sufficient to 
ensure a valid blood sample (Cole et al, 2007). 
Potential problems in CVADs in Children 
There are numerous complications which can occur when a child has a CVAD and prompt recognition 
and treatment of these is key. Table 2 highlights some potential problems, how to recognise these 
and the necessary treatment. Healthcare professionals should always refer to their local guidelines 
for best practice for their area. 
Complication Signs and Symptoms Treatment 
Infection High temperature Swab any pus 
Redness, swelling or pus 
formation around the insertion 
site 
Redness tracking along the 
tunnel of CVAD  
Pain in the insertion site or 
surrounding tissue (GAIN, 
2014) 
Blood cultures from the port 
and from a peripheral vein (if 
possible) 
IV antibiotics according to local 
antimicrobial prescribing 
guidelines (GAIN, 2014). 
Cut or break in line Leakage of blood or fluids 
when flushing through a tear 
or hole in the line. 
If possible, move clamp to 
above break in line and clamp. 
If this is not possible then 
apply sterile gauze to the area 
and seek further assistance.  
Breaks in CVAD lines can 
sometimes be repaired but on 
occasion may need to be 
replaced (Zens et al, 2019). 
Line falls out Line is either fully or partially 
out of place 
Blood loss from insertion site 
Apply sterile gauze and 
pressure over the insertion site 
Seek urgent surgical review 
Blocked line Increasing pressure when 
flushing line 
Unable to flush line 
Local guidelines may vary but 
thrombolytic therapy such as 
alteplase can be used.  
Surgical intervention may be 
required (Baskin et al, 2009). 
Unable to obtain aspirate from 
line 
Resistance when trying to 
aspirate CVAD. 
Treatment may vary 
depending on the type of 
CVAD.  
Local guidelines may vary but 
thrombolytic therapy such as 
alteplase could be used. 
Patients should be observed 
for discomfort on flushing and 
oedema at the line site. 
In Implanted Ports a change of 
needle may resolve the issue. 
Refer to local guidelines. 
Thrombosis Oedema of the face, neck, 
arms or shoulders  
Venous distension/collateral 
circulation  
Pain, aching or tenderness of 
the chest, shoulder or arm  
Numbness or tingling of the 
fingers, hands or arms  
Skin discolouration, 
particularly of the arms and 
hands (GAIN, 2014) 
Further blood testing and Ultra 
Sound Scans will be required 
but treatment is likely to be 
pharmacological with heparin 
(NICE, 2015a). 
Reassurance during CVAD access and care 
Having a CVAD inserted and used can be a source of physical and mental distress for children and 
young people. Depending on the CVAD in place, there is a risk of pain, altered body image, needle 
phobia and long term complications. Children’s nurses caring for children with CVADs need to use 
their communication skills to explain the needs for the CVAD and distraction techniques to support 
the child and family. ‘Using play as a distraction technique for children undergoing medical 
procedures’ is a companion article in this ‘at a glance’ series which offers vital information on the 
use of distraction in children’s nursing (Drape and Greenshields, 2020). 
 
Antimicrobial use in Children with CVADs 
There is a growing body of knowledge which suggests that the use of an antimicrobial agent, 
specifically Octenisan in paediatrics, is beneficial for skin decolonisation prior to CVAD insertion 
(Hübner, Siebert & Kramer, 2010; Guys & St Thomas' NHS Foundation Trust, 2017). Healthcare 
professionals should follow local guidelines on the use of antimicrobials, but it is often indicated that 
children be washed using Octenisan for 1 week before a CVAD insertion and then 5 days per week 
for the duration of line insertion. 
Due to the need for antimicrobial stewardship in the NHS, to ensure that healthcare professionals 
reduce the unnecessary use and prescriptions of antimicrobials, the use of antimicrobial medications 
in children with CVADs should be closely monitored (DH, 2019b). Following NICE guidance (2015), 
healthcare professionals must prescribe the shortest effective course of antimicrobials where 
needed and ensure that the most appropriate dose of antimicrobials is used. All healthcare 
professionals have a role to play in monitoring the use of antimicrobials in children with CVADs but it 
is the responsibility of specific antimicrobial stewardship teams to review prescribing of 
antimicrobials (NICE, 2015). Antibiotic locks should not routinely be used to prevent CVAD related 
bloodstream infections (NICE, 2017). 
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